News for 'drug factory'

COVID-19: You can SAVE your life!

COVID-19: You can SAVE your life!

Rediff.com14 Oct 2020

'Try to get in 30 to 60 minutes of a brisk walk every day, like my grandparents would do in the village -- twice a day they would go for morning walks and they would go after dinner.'

Ranbaxy brands to stay alive

Ranbaxy brands to stay alive

Rediff.com8 Aug 2014

Sun Pharma to retain these in most markets; US could be the exception, where the Ranbaxy name has taken a hit.

Ranbaxy recalls some batches of generic Lipitor in latest quality blow

Ranbaxy recalls some batches of generic Lipitor in latest quality blow

Rediff.com10 Mar 2014

The recall is the latest in a series of problems to hit Ranbaxy, which has had all its India factories stopped from sending drugs and ingredients to the United States.

'In the short term, the markets may remain weak due to rising Covid cases'

'In the short term, the markets may remain weak due to rising Covid cases'

Rediff.com7 May 2021

'In the short term, we may see some disruptions due to Covid, but in the medium-to-long term, we should keep an eye on US inflation and 10-year bond yields.'

Why 1,700 employees of Pfizer's India arm may lose their jobs

Why 1,700 employees of Pfizer's India arm may lose their jobs

Rediff.com10 Jan 2019

A key lesson for the pharmaceutical sector in this case is to not downplay the significant impact that regulatory non-compliance can have on operations.

Ranbaxy provisions for settlement with US

Ranbaxy provisions for settlement with US

Rediff.com30 Jul 2014

The Gurgaon-headquartered drug maker, set to be acquired by another leading domestic company, Sun Pharmaceutical Industries, reported a consolidated net loss of Rs 186 crore for the quarter ended June.

Don't need to sell assets, can pay fine: Ranbaxy brothers

Don't need to sell assets, can pay fine: Ranbaxy brothers

Rediff.com25 May 2016

In 2013, Daiichi had launched the arbitration proceedings in Singapore.

Sun, Ranbaxy may be asked to sell some businesses for CCI approval to merger

Sun, Ranbaxy may be asked to sell some businesses for CCI approval to merger

Rediff.com15 Oct 2014

A source said the competition watchdog would by next month suggest 'structural remedies' that included selling key drug segments as conditions for clearing the country's largest pharmaceutical industry merger.

Mafia Inc Italy's largest company

Mafia Inc Italy's largest company

Rediff.com24 Oct 2007

About 80 per cent of Sicilian businesses cough up a pizzo, of as much as 350 pounds a month. However, the burgeoning power of Cosa Nostra in Sicily, the Camorra in Naples, the 'Ndrangheta in Calabria and the Sacra Corona Unita in Puglia, has led to the infiltration of bigger businesses as well.

Sun-Ranbaxy merger clears last hurdle

Sun-Ranbaxy merger clears last hurdle

Rediff.com10 Mar 2015

On January 31, the US Federal Trade Commission cleared the merger.

Ranbaxy may lose $140 mn on US ban

Ranbaxy may lose $140 mn on US ban

Rediff.com23 Sep 2008

Ranbaxy Laboratories, India's biggest drugmaker, may lose as much as $140 million of revenue in 2009 after the US drug regulator blocked sale of more than 30 generic medicines and 7 APIs made in two factories of the company, according to analysts.

Why you must watch out for weekend heart attacks

Why you must watch out for weekend heart attacks

Rediff.com10 Mar 2018

According to a study,it is twice as likely to kill young patients during weekends.

Chinese toys face another major recall

Chinese toys face another major recall

Rediff.com8 Nov 2007

In yet another setback to the Chinese toy industry, millions of toys made in the country are being withdrawn from the US and Australia as they allegedly contained a chemical which mimics the reaction caused by a date-rape drug and could lead to children slipping into coma. Moose Enterprise of Melbourne, Australia, the manufacturer of the popular toy called Aqua Dots, blamed the reaction on substation by a Chinese factory of toxic glue for a safe glue.

Producing vaccines is not like making 2 minutes noodles

Producing vaccines is not like making 2 minutes noodles

Rediff.com27 May 2021

'Even if Serum Institute and Bharat Biotech were successful in ramping up production overnight, what happens to the capacity after the demand from India is met?' asks Sanjeev Nayyar.

Timely facilitation of COVID-19 kits will help Sino-India ties: Envoy

Timely facilitation of COVID-19 kits will help Sino-India ties: Envoy

Rediff.com14 Apr 2020

As its factories resumed operations after over two-month of grim battle against coronavirus, China is busy tapping into the vast business opportunities of export of key medical goods, specially ventilators and personal protection equipment (PPE), across the world, including India, where both private and government bodies are placing orders for the import of these products.

Three movies you must watch!

Three movies you must watch!

Rediff.com12 Nov 2019

Indira Kannan picks Made in Bangladesh, Greed, Moothon.

Now, US FDA gets a call from Indian pharma companies

Now, US FDA gets a call from Indian pharma companies

Rediff.com27 Oct 2013

The Indian Pharmaceutical Alliance has approached regulator for a dialogue to understand the concern raised by it

Cadbury faces prosecution

Cadbury faces prosecution

Rediff.com7 Oct 2003

US regulator not happy with Sun Pharma's reply on import alert

US regulator not happy with Sun Pharma's reply on import alert

Rediff.com21 May 2014

In March, the FDA had issued an import alert, banning formulations and active pharmaceutical ingredients from the factory.

J&J licence to make cosmetics at Mulund plant cancelled

J&J licence to make cosmetics at Mulund plant cancelled

Rediff.com25 Jun 2013

The company has been held responsible for the violation of the Drugs and Cosmetic Act, 1940 and the rules framed in 1945.

Drugmakers draw more FDA scrutiny as US imports rise

Drugmakers draw more FDA scrutiny as US imports rise

Rediff.com13 Sep 2013

And when an inspector asked about the contents of unlabelled vials in the laboratory glassware washing area, a plant worker dumped them down a sink and said the contents could not be determined, according to a July 18 letter from the US Food and Drug Administration to Wockhardt, which makes sterile injectable drugs and various forms of insulin.

Worms found in chocolate packet

Worms found in chocolate packet

Rediff.com3 Oct 2003

Sensex, Nifty lose their way, end on a negative note

Sensex, Nifty lose their way, end on a negative note

Rediff.com2 Nov 2017

A widening probe by US authorities involving top drug companies following complaints of price fixing of generics was a point of worry for the participants, said analysts.

'In Bhopal, every rule in the vaccine trial book has been broken'

'In Bhopal, every rule in the vaccine trial book has been broken'

Rediff.com15 Jan 2021

'We are rolling out a vaccine when we don't even have the phase 2 trial results; forget about phase 3 trial results.' 'Why are we playing with people's lives?'

FDA to prosecute Cadbury for insect infestations

FDA to prosecute Cadbury for insect infestations

Rediff.com6 Oct 2003

A report was positive for the presence of two dead and one live insect, FDA Commissioner Uttam Khobargade said in Mumbai.

Cadbury's 2nd plant under lens

Cadbury's 2nd plant under lens

Rediff.com6 Oct 2003

Soccer legend Maradona mourns 'second father' Castro

Soccer legend Maradona mourns 'second father' Castro

Rediff.com27 Nov 2016

For soccer great Diego Maradona, Cuban revolutionary Fidel Castro was more than a friend and fellow Latin American legend, he was "a second father." Maradona said Castro's death late on Friday hit him like a tennis ball to the chest served by Juan Martin del Potro, the Argentine player he cheered on in the Davis Cup final where he received the news. "I wept uncontrollably," Maradona told reporters on the sidelines of the tennis tournament. "After my father, it's the deepest sorrow I know."

Investors concerned about Wockhardt

Investors concerned about Wockhardt

Rediff.com17 Oct 2013

The rap from both the US and UK drug regulators, including the latest one from the latter, has hit the scrip.

Myth and Reality of Manipur is in Its Sport

Myth and Reality of Manipur is in Its Sport

Rediff.com7 Aug 2021

Olympic Silver medalist Mirabai Chani's feat is a story of grit, dedication and desire, but it isn't unique. In Manipur, discovers Vaibhav Raghunandan.

Reforms are about implementation, not announcements

Reforms are about implementation, not announcements

Rediff.com12 Oct 2020

'The promises of netas and babus and new laws, however well-meaning, mean little.' 'What matters is implementation on the ground.' 'Every law is finally implemented by a vast army of offici

Coronavirus: India Inc's 5-point wishlist for Modi

Coronavirus: India Inc's 5-point wishlist for Modi

Rediff.com24 Mar 2020

Business leaders, among others, ask govt to let go of fiscal target, seek stimulus, and direct cash transfer.

Mumbai to build Wuhan-like hospital to treat COVID-19 patients

Mumbai to build Wuhan-like hospital to treat COVID-19 patients

Rediff.com7 May 2020

The hospital, in the commercial hub of Bandra-Kurla Complex, will serve as an isolation facility for non-critical COVID-19 patients. Expected to be ready in a fortnight, the new makeshift facility can be scaled up to 5,000 beds, if needed. The Brihanmumbai Municipal Corporation will run the hospital that will have, among other things, oxygen facilities and pathological laboratories. Sohini Das reports.

The mistakes Daiichi Sankyo made in the Ranbaxy deal

The mistakes Daiichi Sankyo made in the Ranbaxy deal

Rediff.com12 May 2016

The FDA actions eventually led to a $500-million fine for Ranbaxy as well as the effective mothballing of many of its Indian factories.

Sun gets US trade regulator nod for Ranbaxy merger

Sun gets US trade regulator nod for Ranbaxy merger

Rediff.com1 Feb 2015

Torrent to buy Ranbaxy's anti-bacterial generic

Suspected human hair in tablet cited in Ranbaxy ban

Suspected human hair in tablet cited in Ranbaxy ban

Rediff.com18 Sep 2013

Ranbaxy, which is 63.5 per cent-owned by Japan's Daiichi Sankyo Co and gets more than 40 per cent of its sales from the United States, did not immediately respond to a request on Wednesday for comment on the FDA observations.

Lessons from anti-profiteering order against HUL

Lessons from anti-profiteering order against HUL

Rediff.com21 Jan 2019

The investigation against HUL was initiated on the basis of an anonymous complaint. It alleged 'profiteering' of around Rs 535 crore between November 15, 2017, and February 28, 2018.

How the world will change after coronavirus

How the world will change after coronavirus

Rediff.com23 Mar 2020

'Tens of millions will be working from home for months at a time, which means the smartest brains in business will be focussed on creating more efficient WFH processes,' predicts Devangshu Datta.

'UP voters are not going to forget Covid trauma'

'UP voters are not going to forget Covid trauma'

Rediff.com23 Jun 2021

'Every family in UP has been deeply affected in this second wave.' 'It has only been denial, denial, and denial by the incumbent CM.'

Can 'hatred for China' be business opportunity for India?

Can 'hatred for China' be business opportunity for India?

Rediff.com26 May 2020

Work is underway in identifying global companies in sectors ranging from electronics, auto components and medical equipment to shift part of their existing or incremental manufacturing to India.

After the lockdown: How will government treat us?

After the lockdown: How will government treat us?

Rediff.com16 May 2020

'There are many questions that come to mind as we consider the reality of India and what Indians will be expected to do from the time this lockdown is opened up,' notes Aakar Patel.